DIGOXIN AND PHENYTOIN ANALYSES AS PART OF CONSULTATIONS IN CLINICAL-PHARMACOLOGY - A STUDY ON THE USE OF DRUGS

被引：10

作者：

BERGMAN, U ^{[1
]}

RANE, A ^{[1
]}

SJOQVIST, F ^{[1
]}

WIHOLM, BE ^{[1
]}

机构：

[1] HUDDINGE UNIV HOSP,KAROLINSKA INST DEPT INTERNAL MED,S-14186 HUDDINGE,SWEDEN

来源：

THERAPEUTIC DRUG MONITORING | 1981年 / 3卷 / 03期

关键词：

D O I：

10.1097/00007691-198103000-00006

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：259 / 269

页数：11

共 17 条

[1]

Alvan G, 1975, Lakartidningen, V72, P2621

[2] USE OF DIGOXIN IN A LOW-DENSITY POPULATION AREA IN SWEDEN [J].

BERGMAN, U ;

SJOQVIST, F ;

SODERHIELM, L .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 10 (01) :19-24

[3]

BERGMAN U, 1979, ACTA MED SCAND, V205, P79

[4] MICROMETHOD FOR DETERMINATION OF DIPHENYLHYDANTOIN IN PLASMA AND CEREBROSPINAL-FLUID - COMPARISON BETWEEN A GAS-CHROMATOGRAPHIC AND A SPECTROPHOTOMETRIC METHOD [J].

BERLIN, A ;

BORGA, O ;

AGURELL, S ;

SJOQVIST, F ;

LUND, L .

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1972, 29 (03) :281-&

[5]

BOETHIUS G, 1978, CLIN PHARMACOL THER, V24, P255

[6]

COLLSTE P, 1976, ARZNEIMITTEL-FORSCH, V26, P1255

[7]

CROOKS J, 1967, LANCET, V1, P668

[8] REDUCTION OF DIGOXIN TOXICITY ASSOCIATED WITH MEASUREMENT OF SERUM LEVELS - REPORT FROM BOSTON COLLABORATIVE DRUG SURVEILLANCE PROGRAM [J].

DUHME, DW ;

GREENBLATT, DJ ;

KOCHWESE.J .

ANNALS OF INTERNAL MEDICINE, 1974, 80 (04) :516-519

[9]

HAYNES RB, 1977, MAY WORKSH S COMPL

[10]

JOHNSTON GD, 1978, BRIT HEART J, V40, P1

← 1 2 →